1. Home
  2. CVAC vs ACDC Comparison

CVAC vs ACDC Comparison

Compare CVAC & ACDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVAC
  • ACDC
  • Stock Information
  • Founded
  • CVAC 2000
  • ACDC 2014
  • Country
  • CVAC Germany
  • ACDC United States
  • Employees
  • CVAC N/A
  • ACDC N/A
  • Industry
  • CVAC Biotechnology: Pharmaceutical Preparations
  • ACDC Oilfield Services/Equipment
  • Sector
  • CVAC Health Care
  • ACDC Energy
  • Exchange
  • CVAC Nasdaq
  • ACDC Nasdaq
  • Market Cap
  • CVAC 924.3M
  • ACDC 1.1B
  • IPO Year
  • CVAC 2020
  • ACDC 2022
  • Fundamental
  • Price
  • CVAC $3.59
  • ACDC $7.69
  • Analyst Decision
  • CVAC Hold
  • ACDC Hold
  • Analyst Count
  • CVAC 3
  • ACDC 5
  • Target Price
  • CVAC $10.00
  • ACDC $7.40
  • AVG Volume (30 Days)
  • CVAC 1.2M
  • ACDC 442.9K
  • Earning Date
  • CVAC 11-12-2024
  • ACDC 03-12-2025
  • Dividend Yield
  • CVAC N/A
  • ACDC N/A
  • EPS Growth
  • CVAC N/A
  • ACDC N/A
  • EPS
  • CVAC N/A
  • ACDC N/A
  • Revenue
  • CVAC $70,565,734.00
  • ACDC $2,225,300,000.00
  • Revenue This Year
  • CVAC $742.57
  • ACDC N/A
  • Revenue Next Year
  • CVAC N/A
  • ACDC N/A
  • P/E Ratio
  • CVAC N/A
  • ACDC N/A
  • Revenue Growth
  • CVAC 75.11
  • ACDC N/A
  • 52 Week Low
  • CVAC $2.22
  • ACDC $5.16
  • 52 Week High
  • CVAC $5.28
  • ACDC $9.75
  • Technical
  • Relative Strength Index (RSI)
  • CVAC 45.89
  • ACDC 46.77
  • Support Level
  • CVAC $3.70
  • ACDC $7.00
  • Resistance Level
  • CVAC $4.09
  • ACDC $9.40
  • Average True Range (ATR)
  • CVAC 0.22
  • ACDC 0.51
  • MACD
  • CVAC -0.09
  • ACDC -0.14
  • Stochastic Oscillator
  • CVAC 12.05
  • ACDC 28.75

About CVAC CureVac N.V.

CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid, or mRNA. The company was founded in 2000 and had its initial public offering in August 2020. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and Covid vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.

About ACDC ProFrac Holding Corp.

ProFrac Holding Corp is engaged in providing hydraulic fracturing, completion services, and other complementary products and services to upstream oil and gas companies engaged in the exploration and production of North American unconventional oil and natural gas resources. Its operations are focused in West Texas, East Texas/Louisiana, South Texas, Oklahoma, Uinta, and Appalachian. The company operates in three segments: stimulation services, manufacturing, and proppant production. Stimulation services, which generate the majority of the revenue for the company operate a fleet of mobile hydraulic fracturing units and other auxiliary equipment that generates revenue by providing stimulation services.

Share on Social Networks: